People with cirrhosis are at an increased risk of liver cancer. Treatment may include surgery, a liver transplant, ablation therapy (a needle or probe is used to kill cancer cells), embolization ...

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer and spread through the blood or lymphatic system. The liver is a common ...

Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

The American Cancer Society’s estimates for primary liver cancer and intrahepatic bile duct cancer in the United States for 2025 are: About 42,240 new cases (28,220 in men and 14,020 in women) will be ...

Recent studies highlight breakthroughs in medical treatments. A novel monoclonal antibody cocktail has shown promise in ...

Liver cancer is a serious and deadly cancer ... pembrolizumab, and transarterial chemoembolization (TACE) significantly improves progression-free survival compared to TACE alone, addressing ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly ... called transarterial chemoembolization (TACE), which shrinks the cancer by delivering ...

Background: Currently, inoperable hepatocellular carcinoma (HCC) is treated by both transarterial radioembolization (TARE) and transarterial chemoembolization (TACE). However, their relative efficacy ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...